Abeta-IN-6 is an orally bioavailable small molecule for Alzheimers disease research. It exhibits neuroprotective properties by inhibiting Abeta oligomerization, reducing microglial cytokine release, and activating the Nrf2 antioxidant pathway, as demonstrated in both cellular and in vivo oxidative stress models.
Molekulargewicht:
473.56
Formel:
C28H31N3O4
Target-Kategorie:
Others,Beta Amyloid,Nrf2
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
